Skip to content
Tuesday, September 22, 2020
AHCIPA

AHCIPA

Accountable Health Care IPA

  • Home
  • Behavioral Assessment Goals
  • Mission and Core Values
  • Benefits to Providers and Patients
  • Practice Guidelines
  • Contact Us
You are Here
  • Home
  • Provider Health Services

Tag: Provider Health Services

What Are Provider Health Services?
Facts

What Are Provider Health Services?

July 10, 2020August 10, 20204 min read

What are provider health services? How can they help people reach and maintain overall health? This article will talk about these kinds of services and

Read More

Provider Health Services

Recent Posts

  • Orthodontic Services From Children To Adults
  • Why Should You Buy Wholesale Medical Supplies?
  • Breast Enlargement Surgery (What To Expect From This Procedure)
  • What Is The Value Of A Health Check Up?
  • Can An Emergency Dentist (Open 24 Hours) Prevent Dental Problems?

Categories

  • Facts
  • General Health
  • Plastic Surgery

RSS Other Health Care News

  • How Covid-19 is driving regional innovation in digital health
    In line with the persistent shift to remote medicine, we are seeing innovation happening in more distributed medical technology regions.
    Craig Cooper
  • Mayo’s Chief Digital Officer: The hospital of the future isn’t just about technology
      Mayo Clinic’s new chief digital officer sees an opportunity to improve the patient experience and more broadly change how healthcare is delivered. Coming regulatory changes around price transparency and telehealth coverage are also expected to change patient care.
    Elise Reuter
  • La FDA, c’est moi: In memo, HHS’ Azar asserts power to sign new rules, traditionally purview of agencies’ lawyers
    The New York Times reported that in a memo, Alex Azar stated that the power to sign new rules is “reserved” for him, a move that one expert called a “power grab.” It is unclear how it will affect authorizations of vaccines against the coronavirus.
    Alaric DeArment
  • Amgen publishes, presents data on therapy with ‘undruggable’ target
    Sotorasib, a KRAS G12C inhibitor, showed an overall response rate and duration of response that analysts called approvable, but they noted the results have waned over time, and combinations may be the way forward.
    Alaric DeArment
  • On the agenda for INVEST Digital Health virtual Day 1: Hospital innovation and startups for chronic conditions, value-based care
    The day will include a panel discussion, How Hospital Innovation is Changing Amidst a Pandemic, and the first day of our startup contest Pitch Perfect.
    MedCity News
  • Roche drug that previously failed in Covid-19 pneumonia shows efficacy in Phase III study
    Actemra reduced the percentage of patients with Covid-19 pneumonia who progressed to requiring mechanical ventilation, but did not show an improvement in mortality, time to discharge or improvement on an ordinal scale of clinical status. Results of the Phase III COVACTA study, announced in July, were negative.
    Alaric DeArment

Subscribe to Us!

Our Pages

  • Privacy Policy
  • Terms and Conditions
  • Sitemap
  • Cookies Policy
  • Disclaimer

Also Sponsored By:

We strive to become the leading integrated health service organization dedicated to promoting members personal health through improved communication, health maintenance, and coordinated delivery of care.


Proudly powered by WordPress | Theme: Refined News by Candid Themes.